<?xml version="1.0" encoding="UTF-8"?><rss version="0.92">
<channel>
	<title>FDA Voice &#187; 2012 &#187; March</title>
	<link>http://blogs.fda.gov/fdavoice</link>
	<description></description>
	<lastBuildDate>Tue, 18 Jun 2013 15:09:37 +0000</lastBuildDate>
	<docs>http://backend.userland.com/rss092</docs>
	<language>en</language>
	<!-- generator="WordPress/3.3.1" -->

	<item>
		<title>Getting More Accurate Tobacco Information to Consumers</title>
		<description><![CDATA[By: Margaret Hamburg, M.D. Tobacco use is the leading preventable cause of disease and death in our country. And this Administration is committed to implementing strategies that will stop our nation’s youth from starting to use tobacco and also help &#8230; <a href="http://blogs.fda.gov/fdavoice/index.php/2012/03/getting-more-accurate-tobacco-information-to-consumers/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<link>http://blogs.fda.gov/fdavoice/index.php/2012/03/getting-more-accurate-tobacco-information-to-consumers/</link>
			</item>
	<item>
		<title>Making it Real out in the Regions</title>
		<description><![CDATA[By:  Alan Bennett Making it real. It’s a dilemma we all face at the FDA when trying to explain many of our regulatory decisions. I face it every year when I give the &#8220;Regulation of Drugs and Medical Devices&#8221; lecture &#8230; <a href="http://blogs.fda.gov/fdavoice/index.php/2012/03/making-it-real-out-in-the-regions/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<link>http://blogs.fda.gov/fdavoice/index.php/2012/03/making-it-real-out-in-the-regions/</link>
			</item>
	<item>
		<title>FDA Voice Interviews Lawrence R. Deyton, M.S.P.H., M.D.</title>
		<description><![CDATA[FDA Voice: What is your current position at FDA and, briefly, what is the mission of the Center for Tobacco Products? Dr. Deyton: I joined FDA in the fall of 2009 as Director of FDA’s Center for Tobacco Products. CTP &#8230; <a href="http://blogs.fda.gov/fdavoice/index.php/2012/03/fda-voice-interviews-lawrence-r-deyton-m-s-p-h-m-d/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<link>http://blogs.fda.gov/fdavoice/index.php/2012/03/fda-voice-interviews-lawrence-r-deyton-m-s-p-h-m-d/</link>
			</item>
	<item>
		<title>Diagnosing TB, One Test at a Time</title>
		<description><![CDATA[By Alberto Gutierrez, Ph.D. For centuries tuberculosis, or simply TB as it is commonly referred to today, was fatal for millions of people living around the world. Most people infected with the bacterium Mycobacterium tuberculosis, the most common cause of &#8230; <a href="http://blogs.fda.gov/fdavoice/index.php/2012/03/diagnosing-tb-one-test-at-a-time/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<link>http://blogs.fda.gov/fdavoice/index.php/2012/03/diagnosing-tb-one-test-at-a-time/</link>
			</item>
	<item>
		<title>Report Adverse Events and Sign Up to Get Medical Product Information with MedWatch</title>
		<description><![CDATA[By: Jay Wattenberg Have you ever wondered how FDA hears about side effects of drugs and other medical products once they are on the market? Or how product problems are discovered? FDA gets important reports of problems from the nation&#8217;s &#8230; <a href="http://blogs.fda.gov/fdavoice/index.php/2012/03/report-adverse-events-and-sign-up-to-get-medical-product-information-with-medwatch/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<link>http://blogs.fda.gov/fdavoice/index.php/2012/03/report-adverse-events-and-sign-up-to-get-medical-product-information-with-medwatch/</link>
			</item>
	<item>
		<title>Protecting Against Radiation Contamination &#8211; The Japanese Nuclear Reactor Explosion a Year Later</title>
		<description><![CDATA[By: Kelly Garnick March 11th of last year began as a typical winter day in New England and a routine day at the Winchester Engineering and Analytical Center (WEAC), the FDA laboratory that tests for radiation contamination of food and &#8230; <a href="http://blogs.fda.gov/fdavoice/index.php/2012/03/protecting-against-radiation-contamination-the-japanese-nuclear-reactor-explosion-a-year-later/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<link>http://blogs.fda.gov/fdavoice/index.php/2012/03/protecting-against-radiation-contamination-the-japanese-nuclear-reactor-explosion-a-year-later/</link>
			</item>
	<item>
		<title>National Consumer Protection Week and FDA’s Fight Against Health Fraud Scam</title>
		<description><![CDATA[By: Margaret Hamburg, M.D. This week, FDA joins 29 other government agencies and a host of private groups to highlight National Consumer Protection Week, an annual event for consumers to learn how to protect their privacy, manage money and debt, &#8230; <a href="http://blogs.fda.gov/fdavoice/index.php/2012/03/national-consumer-protection-week-and-fdas-fight-against-health-fraud-scam/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<link>http://blogs.fda.gov/fdavoice/index.php/2012/03/national-consumer-protection-week-and-fdas-fight-against-health-fraud-scam/</link>
			</item>
	<item>
		<title>Keeping the Focus on Scientific Integrity</title>
		<description><![CDATA[By: Jesse L. Goodman, M.D., M.P.H. Science, both its quality and its integrity, is key to everything we do at FDA. As a physician and researcher, science has always been central to the decisions I make at the bench or &#8230; <a href="http://blogs.fda.gov/fdavoice/index.php/2012/03/keeping-the-focus-on-scientific-integrity/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<link>http://blogs.fda.gov/fdavoice/index.php/2012/03/keeping-the-focus-on-scientific-integrity/</link>
			</item>
	<item>
		<title>FDA’s Strategy of Creating Alliances</title>
		<description><![CDATA[By:  Joy Johanson, MPH Webster’s defines “alliance” as “an association to further the common interests of the members.” When it comes to food safety, the common interest is pretty clear&#8211;reducing the burden of foodborne illness in the United States where &#8230; <a href="http://blogs.fda.gov/fdavoice/index.php/2012/03/fdas-strategy-of-creating-alliances/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<link>http://blogs.fda.gov/fdavoice/index.php/2012/03/fdas-strategy-of-creating-alliances/</link>
			</item>
	<item>
		<title>Advocating for Patients with Rare Diseases</title>
		<description><![CDATA[By: Debra Y. Lewis, OD MBA This week we commemorate the fifth annual Rare Disease Day, a global campaign to raise awareness of the millions of people worldwide who suffer from rare diseases. In the United States, about 30 million &#8230; <a href="http://blogs.fda.gov/fdavoice/index.php/2012/03/advocating-for-patients-with-rare-diseases/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<link>http://blogs.fda.gov/fdavoice/index.php/2012/03/advocating-for-patients-with-rare-diseases/</link>
			</item>
</channel>
</rss>
